CLOSED LOOP SYSTEM IN TYPE 1 DIABETES MANAGEMENT COMPARISON WITH PRAMLINTIDE Vs EXENATIDE.
Phase of Trial: Phase I
Latest Information Update: 20 Feb 2017
At a glance
- Drugs Exenatide (Primary) ; Pramlintide (Primary) ; Insulin
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Acronyms Closedloop
- 01 Jan 2013 Status changed from recruiting to completed as reported by ClinicalTrials.gov.
- 12 Jun 2012 Results in 5 patients presented at the 72nd Annual Scientific Sessions of the American Diabetes Association.
- 02 Feb 2012 Planned end date changed from 1 Aug 2013 to 1 Dec 2013 as reported by ClinicalTrials.gov.